Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs)

Cunha, Burke A.

doi:10.1007/s10096-014-2113-z

Search citation statements

Order By: Relevance

Paper Sections

Select...

Results1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2015

2017

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The electronic search of Medline through PubMed identified 483 titles. Of the 43 reports [ 19 – 61 ] selected for full review, 23 reports [ 38 – 60 ] were excluded for reason before abstraction (Figure 2 ). One additional title [ 61 ] was excluded during record abstraction because key data were missing regarding the use of minocycline.…”

Section: Resultsmentioning

confidence: 99%

Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review

Carris

Pardo

Montero

et al. 2015

Open Forum Infectious Diseases

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review

Carris

Pardo

Montero

et al. 2015

Open Forum Infectious Diseases

View full text Add to dashboard Cite

show abstract

Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations

Cunha

Baron

Cunha

2017

Eur J Clin Microbiol Infect Dis

View full text Add to dashboard Cite

Doxycycline and, to a lesser extent, minocycline, have been used for decades to treat various serious systemic infections, but many physicians remain unfamiliar with their spectrum, interpretation of susceptibility results, pharmacokinetic/pharmacodynamic (PK/PD) properties, optimal dosing regimens, and their activity against MRSA, VRE, and multidrug-resistant (MDR) Gram-negative bacilli, e.g., Acinetobacter sp. This article reviews the optimal use of doxycycline and minocycline to treat a variety of infections and when minocycline is preferred instead of doxycycline.

show abstract

Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs)

Cited by 2 publications

References 22 publications

Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review

Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review

Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations

Contact Info

Product

Resources

About